Skip to main content

iwCLL 2025 Main banner

iwCLL X / Twitter

88 Views

Poster

1707 - Evaluating CLL/SLL Clinical Trials: A Participation-to-Prevalence Analysis Using Institutional and SEER Data from 2012-2024

Primary Author / Presenter(s)

AO

Anna Oh, PhD, MPH, RN

Stanford University
Palo Alto, California, United States

Co-Author(s)

JA

Justin Abuel, BS

Stanford University
Stanford, California, United States
BW

Briana Williams, BS

Stanford Health Care
Palo Alto, California, United States
AM

Alfonso Molina, MD, MPH

Stanford University
Stanford, California, United States
MC

Michael Conte, PA-C

Stanford Health Care
Palo Alto, California, United States
GM

Gabriel Mannis, MD

Stanford University
Stanford, California, United States
WS

William Shomali, MD

Stanford University
Stanford, California, United States
ML

Michaela Liedtke, MD

Stanford University
Stanford, California, United States
JG

Jason Gotlib, MD

Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
Stanford, California, United States
BM

Beverly Mitchell, MD

Stanford University
Stanford, California, United States
TS

Tait Shanafelt, MD

Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford
Stanford, California, United States
BF

Bita Fakhri, MD, MPH

Stanford Cancer Institute, Stanford University
San Francisco, California, United States